MENU

Published on 17/09/2020 2:06:37 PM | Source: Angel Broking Ltd

Quote on Dr. Reddy`s Lab By Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel  https://t.me/InvestmentGuruIndia 

Download Telegram App before Joining the Channel

Below is the Quote on Dr. Reddy's Lab By Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

“Dr. Reddy's Laboratories along with its subsidiaries together announces the launch of over-the-counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the storebrand equivalents of Pataday® Once Daily Relief and Pataday® Twice Daily Relief, in the U.S. market, as approved by the U.S. Food and Drug Administration (USFDA). Dr. Reddy’s Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1% are indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander. The Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% is also indicated for the temporary relief of red eyes. The Pataday® brand had U.S. sales of approximately $31 million since the launch in March 2020 according to IRi*. This is one of the important additions to its OTC product portfolio in the USA for the company. This will be a positive development for the Dr. Reddy's laboratories.”

 

Above views are of the author and not of the website kindly read disclaimer